Conference Coverage: ASH 2025 – Focus on Multiple Myeloma
Expert perspectives on the latest research updates, therapeutic advances, and their application in clinical decision-making for multiple myeloma
FACULTY CHAIR
Rafael Fonseca, MD
Mayo Clinic Cancer Center, Phoenix, AZ
Faculty Members
Hermann Einsele, MD, FRCP
University Hospital Würzburg, Germany
María-Victoria Mateos, MD, PhD
University of Salamanca, Spain
Gareth Morgan, MD, PhD, FRCP, FRCPath
NYU Grossman School of Medicine, New York, NY, USA
Suzanne Lentzsch, MD, PhD
Columbia University Medical Center, New York, NY, USA
Keith Stewart, MBChB, FRCP
University of Toronto, ON, Canada
Sagar Lonial, MD, FACP, FASCO
Emory University Winship Cancer Institute, Atlanta, GA, USA
Leif Bergsagel, MD, FASCO
Mayo Clinic, Phoenix, AZ, USA
KEY TAKEAWAYS
- Smoldering Multiple Myeloma
- NDMM: Transplant-Eligible and -Ineligible Patients
- Relapsed/Refractory and
- CAR T
- Small Molecules, Antibodies, and Bispecifics
